Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost/Brinzolamide vs Cosopt in Glaucoma or Ocular Hypertension
NCT00767481Phase 3Terminated
- Sponsor
- Alcon Inc.
- Start
- Oct 2008
- Primary completion
- Feb 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of travoprost, brinzolamide in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Oct 2008; status: terminated.
02
Drugs
travoprostbrinzolamide
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00767481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767481.